Mary Catherine Thomson
YOU?
Author Swipe
View article: Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure
Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure Open
Background Sacubitril/valsartan improves health outcomes for heart failure with reduced ejection fraction relative to angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers, but it carries higher out‐of‐pocket costs. Nei…
View article: Understanding immunotherapy terminology: An analysis of provider‐patient conversations
Understanding immunotherapy terminology: An analysis of provider‐patient conversations Open
Background Immunotherapy terminology is complex and can be difficult for patients to understand, threatening informed consent. The aims of this exploratory study are to determine whether patients understand immunotherapy terminology and if…
View article: Framing Benefits in Decision Aids: Effects of Varying Contextualizing Statements on Decisions About Sacubitril-Valsartan for Heart Failure
Framing Benefits in Decision Aids: Effects of Varying Contextualizing Statements on Decisions About Sacubitril-Valsartan for Heart Failure Open
Background. Presenting numeric data alone may result in patients underappreciating clinically significant benefits. Contextualizing statements to counter this may raise concern about absence of neutrality. These issues arose during constru…
View article: Reassessing the measurement and presence of therapeutic misconception in a phase 1 setting
Reassessing the measurement and presence of therapeutic misconception in a phase 1 setting Open
Background Therapeutic misconception (TM) refers to research subjects' failure to distinguish the goals of clinical research from standard personal care. TM has traditionally been determined by questioning the patient about the research st…
View article: PREDICTORS OF LIKELIHOOD OF TAKING SACUBITRIL-VALSARTAN AND A HYPOTHETICAL MEDICATION FOR COVID-19
PREDICTORS OF LIKELIHOOD OF TAKING SACUBITRIL-VALSARTAN AND A HYPOTHETICAL MEDICATION FOR COVID-19 Open